BUSINESSQUARTZ
Bank of America is spending $250 million a year on weight loss drugs for employees
Bank of America is allocating $250 million annually for weight loss drugs for employees. CEO Brian Moynihan reported that GLP-1 medications now make up approximately 13% of the company's total healthcare expenditures.
Mentioned
Related Signal
Adjacent reporting
- Bank of America spends more than $250 million on GLP-1s
- Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
- This CEO wants to cover weight loss drugs for employees. They're just too expensive.
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
- UVM Health to suspend weight loss drug coverage for its employees
- Millions of Americans can get Medicare to cover GLP-1s for weight loss starting this week. Here’s how much it costs.